Monocyte-to-Lymphocyte Ratio as a Prognostic Marker in Patients With Acute Respiratory Distress Syndrome: A Retrospective Observational Study

Background and aims: Acute respiratory distress syndrome (ARDS) is a serious and often fatal inflammatory condition of the lungs. Many factors can help guide disease management, and early prognostic markers play a crucial role in this process. In this study, the monocyte-to-lymphocyte ratio (MLR) was compared with both the neutrophil-to-lymphocyte ratio (NLR) and the Acute Physiology and Chronic Health Evaluation IV (APACHE IV) score for predicting 28-day mortality in ARDS. Patients and methods: In this retrospective cohort study, 250 adult patients with ARDS admitted to a tertiary intensive care unit (ICU) from September 2022 to July 2024 were analyzed. The MLR and NLR were calculated within 24 hours of admission and on Days 3 and 5. APACHE IV scores were obtained within 24 hours of admission. Outcomes were assessed at 28 days. The study cohort was validated using propensity score matching. Predictive performance was evaluated using receiver operating characteristic (ROC) curve analysis. Logistic regression was used to identify independent predictors of mortality. Results: The MLR on Day 1 was significantly higher in nonsurvivors (0.93 ± 0.33) than in survivors (0.44 ± 0.33; p < 0.001). The APACHE IV score was the best predictor of mortality (area under the curve (AUC) = 0.876), followed by the MLR (AUC = 0.842) and NLR (AUC = 0.823). An MLR ≥0.74 was independently associated with increased 28-day mortality (adjusted odds ratio (OR) = 5.1, p < 0.001). A higher MLR was associated with lower P/F ratios, increased lactate levels, longer duration of mechanical ventilation, post-ARDS lung mechanical recovery, and longer hospital stays. Conclusions: The MLR is a simple, inexpensive, and independent predictor of 28-day mortality in ARDS, and its predictive value was comparable to that of APACHE IV. The use of the MLR in early risk stratification could help inform clinical decision-making, particularly in low-resource areas.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2026-11-18
DOI
https://doi.org/10.7759/cureus.119895
Primary Topic
Inflammatory Biomarkers in Disease Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Monocyte-to-Lymphocyte Ratio as a Prognostic Marker in Patients With Acute Respiratory Distress Syndrome: A Retrospective Observational Study

Payel Bose, Tanmay Banerjee, Arkaprava Singharoy, Sagnik Das et al.
3 links
Cureus
Inflammatory Biomarkers in Disease Prognosis
article

Monocyte-to-Lymphocyte Ratio as a Prognostic Marker in Patients With Acute Respiratory Distress Syndrome: A Retrospective Observational Study

Payel Bose, Tanmay Banerjee, Arkaprava Singharoy, Sagnik Das, Prerona Bhowmick
article en

Abstract

Background and aims: Acute respiratory distress syndrome (ARDS) is a serious and often fatal inflammatory condition of the lungs. Many factors can help guide disease management, and early prognostic markers play a crucial role in this process. In this study, the monocyte-to-lymphocyte ratio (MLR) was compared with both the neutrophil-to-lymphocyte ratio (NLR) and the Acute Physiology and Chronic Health Evaluation IV (APACHE IV) score for predicting 28-day mortality in ARDS. Patients and methods: In this retrospective cohort study, 250 adult patients with ARDS admitted to a tertiary intensive care unit (ICU) from September 2022 to July 2024 were analyzed. The MLR and NLR were calculated within 24 hours of admission and on Days 3 and 5. APACHE IV scores were obtained within 24 hours of admission. Outcomes were assessed at 28 days. The study cohort was validated using propensity score matching. Predictive performance was evaluated using receiver operating characteristic (ROC) curve analysis. Logistic regression was used to identify independent predictors of mortality. Results: The MLR on Day 1 was significantly higher in nonsurvivors (0.93 ± 0.33) than in survivors (0.44 ± 0.33; p < 0.001). The APACHE IV score was the best predictor of mortality (area under the curve (AUC) = 0.876), followed by the MLR (AUC = 0.842) and NLR (AUC = 0.823). An MLR ≥0.74 was independently associated with increased 28-day mortality (adjusted odds ratio (OR) = 5.1, p < 0.001). A higher MLR was associated with lower P/F ratios, increased lactate levels, longer duration of mechanical ventilation, post-ARDS lung mechanical recovery, and longer hospital stays. Conclusions: The MLR is a simple, inexpensive, and independent predictor of 28-day mortality in ARDS, and its predictive value was comparable to that of APACHE IV. The use of the MLR in early risk stratification could help inform clinical decision-making, particularly in low-resource areas.

Cureus
Manipal Hospital (IN)
Good health and well-being
Inflammatory Biomarkers in Disease Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon